You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – First Analysis Securities on Thursday upgraded NeoGenomics' shares to Strong Buy from a prior Outperform rating after the firm's shares fell 8 percent following its Q4 earnings report and outlook.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.